Alpine Global Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-17,058
Closed -$2.4M 347
2020
Q2
$2.4M Buy
+17,058
New +$2.49M 0.42% 39
2018
Q1
Sell
-16,109
Closed -$2.25M 156
2017
Q4
$2.25M Buy
16,109
+12,985
+416% +$1.81M 0.51% 36
2017
Q3
$406K Buy
+3,124
New +$414K 0.12% 121
2017
Q2
Sell
-23,529
Closed -$2.93M 238
2017
Q1
$2.93M Buy
23,529
+1,701
+8% +$203K 0.76% 22
2016
Q4
$2.52M Buy
+21,828
New +$2.52M 1.18% 21
2015
Q3
Sell
-21,902
Closed -$2.13M 463
2015
Q2
$2.13M Buy
21,902
+1,125
+5% +$113K 0.36% 41
2015
Q1
$2.09M Sell
20,777
-50,191
-71% -$5.1M 0.68% 27
2014
Q4
$7.42M Buy
+70,968
New +$7.48M 1.33% 9

Other funds holding JNJ

Alpine Global Management's JNJ Position: Q3 2020 in Review

Alpine Global Management sold out of Johnson & Johnson (JNJ) in Q3 2020, closing a stake of 17,058 shares — an estimated $2.4M sold.

Alpine Global Management first reported a position in JNJ in Q4 2014 and held it in 8 quarters. The position peaked at $7.42M in Q4 2014. 2,984 funds tracked by Wall St. Rank hold JNJ as of Q3 2020.

  • Alpine Global Management reported no remaining Johnson & Johnson position as of Q3 2020 after selling out during the quarter.
  • Alpine Global Management sold 17,058 Johnson & Johnson shares in Q3 2020, an estimated $2.4M.
  • Alpine Global Management first reported a position in Johnson & Johnson in Q4 2014 and held it in 8 quarters.
  • Alpine Global Management's Johnson & Johnson position peaked at $7.42M in Q4 2014.
  • 2,984 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2020.

Based on Alpine Global Management's 13F filing for Q3 2020, filed 12 Nov 2020.